These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2023 related items for PubMed ID: 16827732

  • 21. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis.
    Ribeiro FV, de Mendonça AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM.
    J Periodontol; 2011 Aug; 82(8):1187-96. PubMed ID: 21284550
    [Abstract] [Full Text] [Related]

  • 22. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [Abstract] [Full Text] [Related]

  • 23. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S, Kwan Tat S, Vusio P, Blanchard F, Gallagher J, Ricard-Blum S, Fortun Y, Padrines M, Rédini F, Heymann D.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):460-7. PubMed ID: 16828054
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Interleukin-1beta and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis].
    Wu YF, Tan C, Zhang JY, Meng S, Guo YH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep 25; 35(5):683-6. PubMed ID: 15460419
    [Abstract] [Full Text] [Related]

  • 26. Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid.
    Tang TH, Fitzsimmons TR, Bartold PM.
    J Clin Periodontol; 2009 Sep 25; 36(9):713-8. PubMed ID: 19570104
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.
    Arthritis Rheum; 2001 May 25; 44(5):1003-12. PubMed ID: 11352231
    [Abstract] [Full Text] [Related]

  • 29. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
    Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P.
    Circulation; 2005 May 17; 111(19):2461-8. PubMed ID: 15883214
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis.
    Duarte PM, Neto JB, Casati MZ, Sallum EA, Nociti FH.
    Oral Dis; 2007 Nov 17; 13(6):594-9. PubMed ID: 17944678
    [Abstract] [Full Text] [Related]

  • 32. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
    Hofbauer LC, Kluger S, Kühne CA, Dunstan CR, Burchert A, Schoppet M, Zielke A, Heufelder AE.
    J Cell Biochem; 2002 Nov 17; 86(4):642-50. PubMed ID: 12210731
    [Abstract] [Full Text] [Related]

  • 33. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 17; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 34. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS, Harrison RF, Balasubramanian SP, Lippitt JM, Evans CA, Reed MW, Holen I.
    J Clin Pathol; 2006 Jul 17; 59(7):716-20. PubMed ID: 16489180
    [Abstract] [Full Text] [Related]

  • 35. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis.
    Goutoudi P, Diza E, Arvanitidou M.
    J Dent; 2004 Sep 17; 32(7):511-20. PubMed ID: 15304296
    [Abstract] [Full Text] [Related]

  • 36. Osteoprotegerin levels in peri-implant crevicular fluid.
    Arikan F, Buduneli N, Kütükçüler N.
    Clin Oral Implants Res; 2008 Mar 17; 19(3):283-8. PubMed ID: 18081868
    [Abstract] [Full Text] [Related]

  • 37. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun 17; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.
    Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K.
    J Clin Periodontol; 2003 Dec 17; 30(12):1046-52. PubMed ID: 15002890
    [Abstract] [Full Text] [Related]

  • 40. Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis.
    Crotti TN, Ahern MJ, Lange K, Weedon H, Coleman M, Roberts-Thomson PJ, Haynes DR, Smith MD.
    J Rheumatol; 2003 Nov 17; 30(11):2319-24. PubMed ID: 14677171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 102.